MARKET

EDAP

EDAP

Edap Tms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.340
-0.070
-2.90%
Opening 15:31 07/14 EDT
OPEN
2.480
PREV CLOSE
2.410
HIGH
2.490
LOW
2.300
VOLUME
54.79K
TURNOVER
--
52 WEEK HIGH
5.39
52 WEEK LOW
1.460
MARKET CAP
68.19M
P/E (TTM)
-390.0000
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average EDAP stock price target is 5.34 with a high estimate of 5.51 and a low estimate of 5.01.

EPS

EDAP News

More
Edited Transcript of EDAP earnings conference call or presentation 14-May-20 12:30pm GMT
Q1 2020 Edap Tms SA Earnings Call
Thomson Reuters StreetEvents · 07/07 02:40
EDAP Appoints Medical Technology Executive Marie Meynadier to its Board of Directors
Ms. Meynadier has more than 20 years of experience in medical technology operations and leadership and most recently served as Chief Executive Officer of EOS Imaging. Together with the Company’s recently announced partnership with Exact Imaging, I believe EDA
GlobeNewswire · 06/30 20:41
EDAP Appoints Frank Van Hyfte as Vice President of Global Sales and Marketing
Mr. Van Hyfte joins EDAP from Exact Imaging, where he most recently served as Executive Vice-President of Worldwide Sales and Marketing. On May 12, 2020, EDAP announced that the Company had entered into an exclusive worldwide distribution agreement with Exact
GlobeNewswire · 05/28 12:35
EDAP TMS S.A. (EDAP): Are Hedge Funds Right About This Stock?
Insider Monkey · 05/27 18:36
EDAP Shares Are Still A Steal, But The Pandemic Could Be A Wrench
Seeking Alpha - Article · 05/19 18:45
EDAP TMS S.A. (EDAP) CEO Marc Oczachowski on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/14 16:40
Edap TMS Q1 EPS $(0.050) Misses $(0.030) Estimate, Sales $8.295M Miss $9.160M Estimate
Edap TMS (NASDAQ:EDAP) reported quarterly losses of $(0.050) per share which missed the analyst consensus estimate of $(0.030) by 66.67 percent. This is a 600 percent decrease over earnings of $0.010 per share from the
Benzinga · 05/13 20:38
EDAP Reports First Quarter 2020 Results and Provides Operational Update
Maintains strong balance sheet with EUR 18.5 million (USD 20.3 million) in cash as of March 31, 2020Signs exclusive worldwide distribution agreement with Exact Imaging to.
GlobeNewswire · 05/13 20:35

Industry

Advanced Medical Equipment & Technology
+1.68%
Healthcare Equipment & Supplies
+1.63%

Hot Stocks

Symbol
Price
%Change

About EDAP

EDAP TMS S.A. (EDAP) is a company that develops, manufactures, promotes and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology. The Company operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The Company invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The Company is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The Company is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.
More

Webull offers kinds of Edap Tms SA (ADR) stock information, including NASDAQ:EDAP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EDAP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EDAP stock methods without spending real money on the virtual paper trading platform.